Cited by 134Schizophrenia research and treatmentMitochondrial Function and PathologyAmino Acid Enzymes and Metabolism

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics

Martins-de-Souza, Daniel, Harris, Laura W., Guest, Paul C., Bahn, Sabine·2011·Antioxidants & Redox Signaling

DOI 10.1089/ars.2010.3459

Open this paper in CoChat — free account

Abstract

Schizophrenia is a psychiatric illness that affects approximately 30 million people worldwide. Converging lines of evidence suggest that mitochondrial function may be compromised in this disorder, and this can lead to perturbations in calcium buffering, oxidative phosphorylation, increased production of reactive oxygen species, and apoptotic factors, which can, in turn, affect neuronal processes such as neurotransmitter synthesis and synaptic plasticity. Proteomics studies in brain and peripheral tissues of schizophrenia patients have provided considerable evidence and identified biomarker fingerprints corresponding to such pathways. Here we review the results of these studies with a focus on the biomarker pattern depicting alterations in energy metabolism and oxidative stress in this debilitating illness. Antioxid. Redox Signal. 15, 2067–2079.

Integrity signals

Registry

Crossref · 10.1089/ars.2010.3459

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
GLUTATHIONE TRANSFERASES
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,565
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Direct analysis of protein complexes using mass spectrometry
Link, A. J., Eng, J. K., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., & Yates, J. R. (1999) · Nature Biotechnology · doi:10.1038/10890 · Cited by 2,218
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology
Gygi, S. P., Corthals, G. L., Zhang, Y., Rochon, Y. P., & Aebersold, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160270797 · Cited by 1,311
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress
Prabakaran, S., SWATTON, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M. T., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 985
Self-citation
Progress with gene‐product mapping of the Mollicutes: Mycoplasma genitalium
Wasinger, V. C., Cordwell, S. J., Poljak, A., Yan, J. X., Gooley, A. A., Wilkins, M. R., Duncan, M. W., Harris, R. J., Williams, K. L., & Humphery‐Smith, I. (1995) · Electrophoresis · doi:10.1002/elps.11501601185 · Cited by 962
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P. B., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome
Tamminga, C. A. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070016003 · Cited by 544
Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder
Johnston-Wilson, N. L., Sims, C. D., Hofmann, J.-P., Anderson, L., Shore, A. D., Torrey, E. F., Yolken, R. H., & the Stanley Neuropathology Consortium (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000696 · Cited by 531
Structural Abnormalities in the Frontal System in Schizophrenia
Andreasen, N. C. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020042006 · Cited by 488
The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia
Horrobin, D. F. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00151-5 · Cited by 456
Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress
Prabakaran, S., SWATTON, J. E., Ryan, M. M., Huffaker, S. J., Huang, J. T.-J., Griffin, J. L., Wayland, M. T., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001532 · Cited by 375
Self-citation
Impaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia
Spelman, L., Walsh, P., Sharifi, N., Collins, P. B., & Thakore, J. H. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02092.x · Cited by 317
Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography
Wolkin, A., Jaeger, J., Brodie, J. D., Wolf, A. P., Fowler, J. S., Rotrosen, J., Gomez-Mont, F., & Cancro, R. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.5.564 · Cited by 293
Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients
Yao, J. K., Leonard, S. S., & Reddy, R. D. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00095-x · Cited by 290
Oxidative Damage and Schizophrenia
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00004 · Cited by 280
Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes
Beasley, C. L., Pennington, K., Behan, A., Wait, R., Dunn, M. J., & Cotter, D. (2006) · PROTEOMICS · doi:10.1002/pmic.200500069 · Cited by 263
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
Fernández-Egea, E., Bernardo, M., Donner, T. W., Conget, I., Parellada, E., Justicia, A., Esmatjes, E., García‐Rizo, C., & Kirkpatrick, B. W. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.052605 · Cited by 242
Metabolic syndrome and mental illness.
Newcomer, J. W. (2007) · PubMed · Cited by 232
Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder
Pennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002098 · Cited by 227
High Throughput Lipidomic Profiling of Schizophrenia and Bipolar Disorder Brain Tissue Reveals Alterations of Free Fatty Acids, Phosphatidylcholines, and Ceramides
Schwarz, E., Prabakaran, S., Whitfield, P. D., Major, H. J., Leweke, F. M., Koethe, D., McKenna, P. J., & Bahn, S. (2008) · Journal of Proteome Research · doi:10.1021/pr800188y · Cited by 225
Self-citation
Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System
Boekema, E. J., & Braun, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600031200 · Cited by 224
Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia
Martins‐de‐Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C., Maccarrone, G., Dias‐Neto, E., & Turck, C. W. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0847-2 · Cited by 203
Self-citation
Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia
Martins‐de‐Souza, D., Maccarrone, G., Wobrock, T., Zerr, I., Gormanns, P., Reckow, S., Falkai, P., Schmitt, A., & Turck, C. W. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.014 · Cited by 198
Self-citation
Three-Dimensional Analysis With MRI and PET of the Size, Shape, and Function of the Thalamus in the Schizophrenia Spectrum
Hazlett, E. A., Buchsbaum, M. S., Byne, W. M., Wei, T.-C., Spiegel-Cohen, J., Geneve, C., Kinderlehrer, R., Haznedar, M. M., Shihabuddin, L., & Siever, L. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1190 · Cited by 197
Mitochondria, Synaptic Plasticity, And Schizophrenia
Ben‐Shachar, D., & Laifenfeld, D. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59011-6 · Cited by 191
Insulin and Insulin-Like Growth Factor-1 Abnormalities in Antipsychotic-Naive Schizophrenia
Venkatasubramanian, G., Chittiprol, S., Neelakantachar, N., Naveen, M. N., Thirthall, J., Gangadhar, B. N., & Shetty, K. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07020233 · Cited by 191
SCHIZOPHRENIA AS A PROSTAGLANDIN DEFICIENCY DISEASE
Horrobin, D. F. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92228-0 · Cited by 188
Increased serum phospholipase A2 activity in schizophrenia: a replication study.
Wf, G., Cv, H., Tj, N., Thuren, T. Y., & Pk, K. (1990) · PubMed · Cited by 186
Multifunctional roles of enolase in Alzheimer’s disease brain: beyond altered glucose metabolism
Butterfield, D. A., & Lange, M. L. B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06397.x · Cited by 180
Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia
Martins‐de‐Souza, D., Gattaz, W. F., Schmitt, A., Maccarrone, G., Hunyadi‐Gulyás, É., Eberlin, M. N., Souza, G. H. M. F., Marangoni, S., Novello, J. C., Turck, C. W., et al. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.11.006 · Cited by 176
Self-citation
A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia
Clark, D., Dedova, I. V., Cordwell, S. J., & Matsumoto, I. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001806 · Cited by 153
Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis
Martins‐de‐Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C., Marangoni, S., Novello, J. C., Maccarrone, G., Turck, C. W., & Dias‐Neto, E. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0156-y · Cited by 146
Self-citation
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation
Martins‐de‐Souza, D., Gattaz, W. F., Schmitt, A., Novello, J. C., Marangoni, S., Turck, C. W., & Dias‐Neto, E. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-17 · Cited by 144
Self-citation
New onset diabetes and atypical antipsychotics
Liebzeit, K. A., Markowitz, J. S., & Caley, C. F. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00127-9 · Cited by 142
Results of phase 3 of the CATIE schizophrenia trial
Stroup, T. S., Lieberman, J. A., McEvoy, J. P., Thomas, S., Swartz, M. S., Keefe, R. S. E., Miller, A. L., Rosenheck, R. A., & Hsiao, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.10.011 · Cited by 141
Schizophrenia, the metabolic syndrome and diabetes
Holt, R. I. G., Peveler, R., & Byrne, C. D. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01199.x · Cited by 139
Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial
Baptista, T., Rangel, N., Fernández, V., Carrizo, E., Fakih, Y. E., Uzcátegui, E., Galeazzi, T., Gutiérrez, M. A. M., Servigna, M., Dávila, A., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.029 · Cited by 138
The Liver-Brain Axis of Alcohol-Mediated Neurodegeneration: Role of Toxic Lipids
de la Monte, S. M., Longato, L., Tong, M., DeNucci, S. M., & Wands, J. R. (2009) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph6072055 · Cited by 137
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study
Schmitt, A., Wilczek, K., Blennow, K., Maras, A., Jatzko, A., Petroianu, G. A., Braus, D. F., & Gattaz, W. F. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.019 · Cited by 134
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues
Huang, J. T.-J., Wang, L., Prabakaran, S., Wengenroth, M., Lockstone, H. E., Koethe, D., Gerth, C. W., Gross, S., Schreiber, D., Lilley, K. S., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002108 · Cited by 133
Self-citation
Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma
Duan, H., Fleming, J. N., Pritchard, D. K., Amon, L. M., Xue, J., Arnett, H. A., Chen, G., Breen, P., Buckner, J. H., Molitor, J. A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23451 · Cited by 128
Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients
Guest, P. C., Wang, L., Harris, L. W., Burling, K., Levin, Y., Ernst, A., Wayland, M. T., Umrania, Y., Herberth, M., Koethe, D., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.81 · Cited by 127
Self-citation
Label‐free LC‐MS/MS quantitative proteomics for large‐scale biomarker discovery in complex samples
Levin, Y., Schwarz, E., Wang, L., Leweke, F. M., & Bahn, S. (2007) · Journal of Separation Science · doi:10.1002/jssc.200700189 · Cited by 119
Self-citation
Multiplex proteomic analysis by two‐dimensional differential in‐gel electrophoresis
Knowles, M. R., Cervino, S., Skynner, H. A., Hunt, S. P., Felipe, C. D., Salim, K., Meneses‐Lorente, G., McAllister, G., & Guest, P. C. (2003) · PROTEOMICS · doi:10.1002/pmic.200300437 · Cited by 118
Self-citation
Increased mitochondrial complex I activity in platelets of schizophrenic patients
Ben‐Shachar, D., Zuk, R., Gazawi, H., Reshef, A., Sheinkman, A., & Klein, E. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001649 · Cited by 113
2-D DIGE Analysis of Liver and Red Blood Cells Provides Further Evidence for Oxidative Stress in Schizophrenia
Prabakaran, S., Wengenroth, M., Lockstone, H. E., Lilley, K. S., Leweke, F. M., & Bahn, S. (2006) · Journal of Proteome Research · doi:10.1021/pr060308a · Cited by 109
Self-citation
Implication du stress oxydant dans la physiopathologie de la schizophrénie : revue de la literature
Fendri, C., Mechri, A., Khiari, G., Othman, A., Kerkeni, A., & Gaha, L. (2006) · L Encéphale · doi:10.1016/s0013-7006(06)76151-6 · Cited by 109
Hepatic Insulin Resistance in Antipsychotic Naive Schizophrenic Patients: Stable Isotope Studies of Glucose Metabolism
van Nimwegen, L. J. M., Storosum, J. G., Blümer, R. M. E., Allick, G., Venema, H. W., de Haan, L., Becker, H. E., van Amelsvoort, T., Ackermans, M. T., Fliers, E., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1167 · Cited by 104
Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease
Aliev, G., Palacios, H. H., Walrafen, B., Lipsitt, A. E., Obrenovich, M. E., & Morales, L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.015 · Cited by 102
Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients
Herberth, M., Koethe, D., Cheng, T. M. K., Krzyszton, N. D., Schoeffmann, S., Guest, P. C., Rahmoune, H., Harris, L. W., Kranaster, L., Leweke, F. M., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.71 · Cited by 100
Self-citation
HYPERGLYÆMIA IN MENTAL DISORDERS
Kooy, F. H. (1919) · Brain · doi:10.1093/brain/42.3.214 · Cited by 100
Glucose abnormalities in the siblings of people with schizophrenia
Fernández-Egea, E., Bernardo, M., Parellada, E., Justicia, A., García‐Rizo, C., Esmatjes, E., Conget, I., & Kirkpatrick, B. W. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.017 · Cited by 98
Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study
Carrizo, E., Fernández, V., Connell, L., Sandia, I., Prieto, D., Mogollón, J., Valbuena, D., Fernández, I., de Baptista, E. A., & Baptista, T. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.05.007 · Cited by 98
Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations
Delaleu, N., Immervoll, H., Cornelius, J., & Jonsson, R. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2375 · Cited by 96
Reliability and validity of a combat exposure index for vietnam era verterans
Janes, G. R., Goldberg, J. H., Eisen, S. A., & True, W. R. (1991) · Journal of Clinical Psychology · doi:10.1002/1097-4679(199101)47:1 · Cited by 96
Proteome analysis of schizophrenia brain tissue
Martins‐de‐Souza, D., Dias‐Neto, E., Schmitt, A., Falkai, P., Gormanns, P., Maccarrone, G., Turck, C. W., & Gattaz, W. F. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903490626 · Cited by 91
Self-citation
Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study
Sivagnanasundaram, S., Crossett, B., Dedova, I. V., Cordwell, S. J., & Matsumoto, I. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700230 · Cited by 88
Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: No changes in docosahexaenoic acid species
Hamazaki, K., Choi, K. H., & Kim, H. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.11.017 · Cited by 84
Multianalyte Profiling of Serum Antigens and Autoimmune and Infectious Disease Molecules to Identify Biomarkers Dysregulated in Epithelial Ovarian Cancer
Bertenshaw, G. P., Yip, P. F., Seshaiah, P., Zhao, J., Chen, T., Wiggins, W. S., Mapes, J. P., & Mansfield, B. C. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0464 · Cited by 82
Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration
Radonjić, N. V., Knežević, I. D., Vilimanovich, U., Kravić-Stevović, T., Marina, L. V., Nikolić, T., Todorović, V., Bumbaširević, V., & Petronijević, N. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.009 · Cited by 75
A Comparative Proteomics Analysis of Rat Mitochondria from the Cerebral Cortex and Hippocampus in Response to Antipsychotic Medications
Ji, B., La, Y., Gao, L., Zhu, H., Tian, N., Zhang, M., Yang, Y., Zhao, X., Tang, R., Ma, G., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr800876z · Cited by 73
Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naïve Patients with Schizophrenia
Yao, J. K., Dougherty, G. G., Reddy, R. D., Keshavan, M. S., Montrose, D. M., Matson, W. R., McEvoy, J. P., & Kaddurah‐Daouk, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009508 · Cited by 73
Reversibility of Hemodynamic Hypofrontality in Schizophrenia
Géraud, G., Arné‐Bes, M., Güell, A., & Bès, A. (1987) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1987.2 · Cited by 72
Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia
Pennington, K., Dicker, P., Dunn, M. J., & Cotter, D. (2008) · PROTEOMICS · doi:10.1002/pmic.200800415 · Cited by 72
Antipsychotic drugs upregulate lipogenic gene expression by disrupting intracellular trafficking of lipoprotein-derived cholesterol
Kristiana, I., Sharpe, L. J., Catts, V. S., Lutze-Mann, L. H., & Brown, A. J. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.62 · Cited by 64
Elevated S100B levels in schizophrenia are associated with insulin resistance
Steiner, J. H., Walter, M., Guest, P. C., Myint, A.-M., Schiltz, K., Panteli, B., Brauner, M., Hg, B., Gos, T., Herberth, M., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.87 · Cited by 62
Self-citation
Isoprostenes as indicators of oxidative stress in schizophrenia
Dietrich‐Muszalska, A., & Olas, B. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701361263 · Cited by 59
Antipsychotic Treatment Alters Protein Expression Associated with Presynaptic Function and Nervous System Development in Rat Frontal Cortex
Ma, D., Chan, M. K., Lockstone, H. E., Pietsch, S., Jones, D. N. C., Cilia, J., Hill, M. D. W., Robbins, M. J., Benzel, I. M., Umrania, Y., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr800983p · Cited by 57
Self-citation
Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients
Miljević, Č., Nikolic, M. R., Nikolić‐Kokić, A., Jones, D. R., Niketić, V., Lečić‐Toševski, D., & Spasić, M. B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.024 · Cited by 53
The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia
Ben‐Shachar, D. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0319-5 · Cited by 53
Phospholipase A2 and the hypofrontality hypothesis of schizophrenia
Gattaz, W. F., & Brunner, J. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90154-4 · Cited by 52
Age- and dose-dependent glucose-induced increases in memory and attention in schizophrenia
Fucetola, R. P., Newcomer, J. W., Craft, S., & Melson, A. K. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00063-3 · Cited by 51
Phase I study of eptifibatide in patients with sickle cell anaemia
Lee, S. P., Ataga, K. I., Zayed, M. A., Manganello, J. M., Orringer, E. P., Phillips, D. R., & Parise, L. V. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06787.x · Cited by 50
Hypofrontality in Schizophrenia: A Review of the Evidence *
Williamson, P. (1987) · The Canadian Journal of Psychiatry · doi:10.1177/070674378703200516 · Cited by 46
Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: A potential approach to identify atherosclerotic disease progression
Gurbel, P. A., Kreutz, R. P., Bliden, K. P., DiChiara, J., & Tantry, U. S. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.08.021 · Cited by 41
Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients
La, Y., Wan, C., Zhu, H., Yang, Y., Chen, Y. S., Pan, Y. X., Feng, G., & He, L. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0607-2 · Cited by 40
Identification of Targeted Analyte Clusters for Studies of Schizophrenia
Cheng, T. M. K., Lu, Y.-E., Guest, P. C., Rahmoune, H., Harris, L. W., Wang, L., Ma, D., Stelzhammer, V., Umrania, Y., Wayland, M. T., et al. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900372-mcp200 · Cited by 27
Self-citation
Abnormal transbilayer distribution of phospholipids in red blood cell membranes in schizophrenia
Nuss, P., Tessier, C., Ferreri, F., Binder, M. D., Peuskens, J., Trugnan, G., Masliah, J., & Wolf, C. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2009.01.009 · Cited by 26
Cerebral Blood Flow Patterns Studied by Rheoencephalography in Schizophrenia
Jacquy, J., Wilmotte, J., Piraux, A., & Noël, G. (2008) · Neuropsychobiology · doi:10.1159/000117536 · Cited by 18
Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia
Fan, X., Liu, E., Pristach, C. A., GOFF, D. C., & Henderson, D. C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.04.010 · Cited by 18
Membrane Pathology in Schizophrenia: Implication for Arachidonic Acid Signaling
Yao, J. K., & Reddy, R. K. (2002) · The Scientific World JOURNAL · doi:10.1100/tsw.2002.870 · Cited by 12
Differences in Protein Profiles in Schizophrenia Prefrontal Cortex Compared to Other Major Brain Disorders
Harris, L. W., SWATTON, J. E., Wengenroth, M., Wayland, M. T., Lockstone, H. E., Holland, A. J., Faull, R. L. M., Lilley, K. S., & Bahn, S. (2007) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.1.1.7 · Cited by 9
Self-citation
Proteomics is not only a biomarker discovery tool
Martins‐de‐Souza, D. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900096 · Cited by 8
Self-citation
Multi‐Analyte Profiling of Post‐Myocardial Infarction Plasma Samples
Escobar, G. P., & Lindsey, M. L. (2007) · The FASEB Journal · doi:10.1096/fasebj.21.6.a865-a · Cited by 6
[Change in the activity of phosphofructokinase in the tissues of rabbits with different stages of fever].
Dubinina, E. E. (1966) · PubMed · Cited by 2

Flagged first, then by citations

Research works printed but not linked: 4

Gulidova GP, , Polianskaia NP. Possible reasons for changes in energy metabolism in brain mitochondria under the influence of schizophrenic patients' serum. Zh Nevropatol Psikhiatr Im S S Korsakova, 73:110–116. 1973.
Heidema CR. Bloedsuikerbepalingen bij psyebiatrische en neurologische patienten. Dissertation, Utrecht, 1918.
Kuznetsova NI, , ZykovIu V, , Sorokina IN. Reaction of anticerebral antibodies in the sera of patients with neuro-psychic disorders to mitochondria and other fractions of brain tissue extract. Bull Eksp Biol Med., 62:47–50. 1966.
10.1016/J.psychires.2010.04.014 · DOI

Sorted by citations

Dendritic spine pathology in schizophrenia
Glausier, J. R., & Lewis, D. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.044 · Cited by 581
Oxidative stress in schizophrenia: An integrated approach
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.008 · Cited by 482
Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression
Allen, J., Romay-Tallón, R., Brymer, K. J., Caruncho, H. J., & Kalynchuk, L. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00386 · Cited by 362
Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304
Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity: Supplementary Issue: Brain Plasticity and Repair
Beckhauser, T. F., Francis-Oliveira, J., & De Pasquale, R. (2016) · Journal of Experimental Neuroscience · doi:10.4137/jen.s39887 · Cited by 301

See all 134

Authors: Martins-de-Souza, D., Harris, L. W., Guest, P. C., & Bahn, S.
Affiliations: University of Cambridge
University of Cambridge (GB)
ORCID: Harris, Laura W.
Guest, Paul C.
Venue: Antioxidants & Redox Signaling
Publisher: SAGE Publications
Published: 2011-10
Volume: 15
Issue: 7
Pages: 2067-2079
ISSN: 1523-0864 (ISSN-L)
1557-7716
DOI: 10.1089/ars.2010.3459
OpenAlex: W2017966444
Cited by: 134
References: 91
Citations by year: 2026: 6 · 2025: 4 · 2024: 2 · 2023: 8 · 2022: 12 · 2021: 5 · 2020: 8 · 2019: 8 · 2018: 8 · 2017: 10 · 2016: 12 · 2015: 8 · 2014: 12 · 2013: 7 · 2012: 13
FWCI: 1.39
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Antioxidants and Redox Signaling (publishedVersion)
PubMed (publishedVersion)
Funders: Stanley Medical Research Institute
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords: schizophrenia, oxidative stress, mitochondrial dysfunction, reactive oxygen species, apoptosis, biomarkers, proteomics, brain, peripheral tissues, calcium buffering, oxidative phosphorylation, synaptic plasticity
MeSH terms: Animals, Energy Metabolism, Humans, Schizophrenia, Oxidative Stress, Proteome, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks